BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 27, 2017

View Archived Issues

Avrobio adds gene therapy for Gaucher disease to pipeline

Read More

EMA committee recommends approval of Axumin for use in prostate cancer

Read More

C4 Therapeutics and Calico partner to develop therapeutics based on targeted protein degradation

Read More

PureTech Health signs licensing and equity agreement with Novartis for mTORC1 programs

Read More

EMA committee recommends approval of Keytruda for classical Hodgkin's lymphoma

Read More

Japanese orphan drug designation for olaparib in BRCA-mutated ovarian cancer

Read More

ImmunoGen decides not to exercise late-stage co-development option for BT-062

Read More

EMA accepts Shionogi's MAA submission for naldemedine

Read More

ANP-C shown to be a novel target for pulmonary arterial hypertension

Read More

TB Alliance sublicenses sutezolid from Medicines Patent Pool

Read More

Boehringer Ingelheim Pharma GmbH discloses free fatty acid receptor 1 agonists

Read More

EMA committee recommends approval of Trumenba

Read More

Erytech reports topline results from phase IIb study of eryaspase in metastatic pancreatic cancer

Read More

First potential fluid-based biomarker of ALS disease progression identified

Read More

Sublingual bacterial vaccine Uromune shows safety and efficacy for recurrent UTIs

Read More

Opdivo approved in Japan for head and neck cancer, recommended for approval in E.U.

Read More

AnGes files IND to begin clinical trial of NF-kappaB decoy for the treatment of disc pain

Read More

Japanese approval expands Sovaldi indication

Read More

Estetrol demonstrates potential utility in the treatment of prostate cancer

Read More

Tagrisso approved in China for NSCLC

Read More

Neuren reports phase II topline results for trofinetide in Rett syndrome

Read More

Bile acid receptor found to be a target for treating neuroinflammation

Read More

EMA validates regulatory filing of tildrakizumab in Europe

Read More

Refixia recommended for approval in E.U.

Read More

VIB and DNAlytics partner on colorectal cancer screening test

Read More

French approval for Eprex within E.U. mutual recognition procedure

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing